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Results: The data of 94 (48 from group A and 46 from group B) patients (53M and
41F) were fully analysed. The median age was 70 (27-92) years and dialysis vintage was
47,2 (7,5÷454,6) months. No difference was found in the demographic characteristics
and treatment parameters. 164 MID sessions and 161 POST sessions were analysed. A
statistically significant difference in RR (%) was found for three MMWmolecules: β-2
Microglobulin (β2M), Complement Factor D (CFD) and Retinol Binding protein
(RBP). Values were 80,1±0,4 in POST vs 81,6±0,4 in MID (p=0,01) for β2M; 72,8±0,8
in POST vs 76,4±0,6 in MID (p=0,0003) for CFD and 24,1±0,9 in POST vs 30,0±0,8 in
MID (p=0,003) for RBPThe other investigated molecules, ADMA, Homocystein,
Leptin and Myoglobin, shown a better MID RR but it is not statistically significant.The
reinfused volume was significantly higher in MID than in POST (average total volume
of 43,63 L in MID vs 20,96 L in POST), but also the amount of reinfused volume in
MID exchanged in its post dilution stage (estimated around the 2/3 as shown in
Maduell publication) is significantly higher (28,8 L in MID vs 20,96 L in POST); this
could explain the depuration capability of MID respect POST for the MMWmolecules,
indeed, was found a linear correlation (R2 0.83) between the delta differences in RR
(RR Mid - RR Post) and MWof molecules (Figure 1). No significant differences
between MID - and POST-dilution were observed for small MWmolecules depuration
(assessed by second generation daugirdas Kt/vd), neither for Albumin loss.
Conclusions:MID is superior to remove MMWmolecules as compared to POST. This
very likely can be related to an higher total amount and efficiency of substituted volume
obtained in the MID group as compared to the POST group.
SP413 ECODIALYSIS: IS IT POSSIBLE TO DESIGN AN
ECO-FRIENDLY SYSTEM?
Martina Ferraresi1, Amina Pereno2, Marta Nazha1, Silvia Barbero2 and Giorgina
B Piccoli1
1University of Torino, Turin, Italy, 2Politecnico of Turin, Turin, Italy
Introduction and Aims: Attention to the environmental impact is still limited in
medicine. Chronic Hemodialysis produces about 600000 tons of plastic wastes per year.
The economic crisis and the awareness of the ecosystem induced to focus attention on
the lifespan of disposables,“from cradle to grave”. A new outlook is presently focussed
on recycle, that is the subsequent start of new cycles leading to a “from cradle to cradle”
model: a “new life” for the waste products (Fig 1). Aim of the study is an analysis of the
disposables employed in chronic hemodialysis, for identifying strategies limiting the
environmental impact and containing the costs.
Methods: An analysis of the disposables employed on dialysis and of their "final
destiny" (the grave) was performed in 3 subsequent bicarbonate dialysis sessions with 3
different dialysis machines. All disposables and packagings were photographed,
classified, weighted and analyzed as for type of materials, possibility to recycle,
contamination with blood or biological fluids.
Results: Each dialysis session produces between 4 and 6 kg of wastes; it may be divided
into about 2 Kg of residual fluids (to be discharged); 2 Kg of "contaminated" wastes (i.e.
in contact with blood or fluids) and 2 kg of "non contaminated" wastes. The
differentiation is crucial, as the weight of contaminated waste products is the main
determinant of disposal cost (approximately 2 Euro/kg in Italy). Furthermore, each
dialysis session produces between 0.9 and 1.4 kg of packaging (cardboard and plastic);
this is usually discharged separately, but where this procedure is not followed, it adds
considerably to the volume and weight of the final wastes.Therefore, a undifferentiated
waste collection may produce over 6 kg of waste products per session; the cost (up to
12-14 Euros) corresponds to 20-40% of the cost of the disposables. While all the
cardboard and paper wastes are readily recyclable, the plastic wastes (non
contaminated) can theoretically enter a dedicated recycle process. In this regard, the
wastes may be classified into "families" of different plastic materials, with different
compatibility for joint recycling. However, in most of the cases the types of plastic
components are not identifiable and separable.Further problems are related
with:-Packaging oversize: the content of most of the packaging of dialysis materials
occupies between 50 and 75% of the space, increasing costs (production, wastes,
transportation).-Emptying: there are no automated systems for emptying residual
fluids after the dialysis session.-Difficult separation of materials: many packages are
laminated made of different components.-Difficult separation of contaminated
material: there is no clear definition of "contaminated".
Conclusions: Attention to the life cycle of the dialysis disposables may conjugate the
attention to our planet, reducing the "mountain" of wastes produced every year; simple
tasks, as careful emptying and differentiating between "contaminated" and "non
contaminated" wastes may lead to a 20% saving of the costs of a dialysis session.
Cooperation with the Industry is needed for designing recycling strategies in keeping
with the modern "cradle to cradle" approach.
SP414 SURFACE, A PARAMETER TO CONSIDER IN HIGH
CONVECTION VOLUME HDF
Alain Ficheux1, Nathalie Gayrard1, Flore Duranton1, Caroline Guzman1,
Ilan Szwarc2, Johanna Bismuth -Mondolfo2, Philippe Brunet3, Marie
Françoise Servel2 and Angel Argilés1,2
1RD – Néphrologie and Université Montpellier 1, EA7288, Montpellier, France,
2Néphrologie Dialyse St Guilhem, Centre de Dialyse de Sète, Sète, France,
3Service de Néphrologie, Hôpital de La Conception – Université Aix-Marseille,
Marseille, France
Introduction and Aims: Convection volume seems to be crucial to the survival
benefits proposed for HDF. However, high convection requires increasing
transmembrane pressure (TMP) which in turn may change the membrane's behaviour
and dialyser's performances.We wanted to characterise the influence of membrane
surface area on the physics and on the removal performances of high convection
volume on-line post-dilutional HDF.
Methods: Twelve stable dialysis patients were successively treated with Amembris® 1.8
m² and 2.3 m² dialysers, and two high convection flows, one (QUF-optimal) obtained
while maintaining the dialysis setting at the maximum in vivo global ultrafiltration
coefficient (GKD-UF max) and the other one at the maximum convection flow
(QUF-max) limited only by the European Best Practice Guidelines (EBPG) (<30%
blood flow / 300 mmHg of TMP) for 1 week each. Continuous sampling of spent
dialysate was performed in all dialysis sessions and total mass of urea, creatinine, and
total proteins were measured. SDS-PAGE scanning of the removed proteins and ELISA
measurements of β-2-microglobulin (B2M), retinol binding protein, lambda light
chains of immunoglobulins, α1-antitrypsin and albumin, were performed.
Results: Increasing from QUF-optimal to QUF-max using the 1.8 m² dialyser resulted
in frequent TMP alarms and only 33% of the sessions reached the prescribed
convection volume. Increasing the dialyser's surface to 2.3 m² significantly decreased
the number of alarms and increased the number of sessions reaching the aimed
convection volume (100% at QUF-optimal and 79% at QUF-max). The total amount
of urea removed was 545±43, 473±32 and 491±44,471±38 mmol/session in HDF with
QUF-optimal and QUF-max respectively for the 1.8 and 2.3 m2 surface (NS). The
corresponding Kt/V values were 1.77±0.05, 1.78±0.05 and 1.75±0.04, 1.75±0.05, (NS).
Removal of low mol wt proteins (observed on SDS-PAGE pattern analysis) and
particularly B2M did not change in the 4 different conditions (274±35, 290±35, 266±24
and 283±35 mg/session (NS)). High molecular weight proteins removal increased with
convection, notably for albumin (from 386±57 to 793±158 with 1.8 m² and from 559
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